CompoAtlas

CLA+

CLA+, licence 80087286: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Acide linoléique conjugué, CONJUGATED LINOLEIC ACID
Licence holder
Laboratoire NewPharma GNTIK Inc. / NewPharma GNTIK Laboratory Inc.
NPN or DIN-HM
80087286
Status
Inactive licence
Licence date
20 July 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Camellia sinensis

Source : Feuille

Extract : Matériel brut sec

Extraction ratio : 4.0:1.0

Dry plant equivalent : 200 milligramme

50.0 milligrammeNot calculated
Chrome

Source : Picolinate de chrome (III)

40.0 microgrammesNot calculated
Acide linoléique conjugué

Source : Acide linoléique conjugué

166.7 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Silice, Phosphate de dicalcium dihydraté

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)3.0 Capsule1.0 Jour(s)

Uses authorised in Canada

Aide à soutenir le métabolisme des graisses Aide l'organisme à métaboliser les lipides Aide l'organisme à métaboliser les glucides (hydrates de carbone)

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80087286

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line